ArticleInternational journal of spine surgery2018

Risk of Cancer Following Lumbar Fusion Surgery With Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2): An Analysis Using a Commercially Insured Patient Population.

Gregory S Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.